Unicycive Therapeutics, Inc.

Over the past 90 days, Unicycive Therapeutics (UNCY) has reported zero cyber incidents and zero red-flag 8-K filings—no bankruptcies, restatements, or officer departures detected in our ingestion pipeline. However, low signal in a 90-day window does not mean low risk; the full Report pulls 12 months of filing history and adds dilution risk scoring, financing trajectory analysis, and AI-detected risk signals that shorter timeframes miss. The full $49 Report adds comprehensive 8-K context, equity structure trends, and institutional ownership patterns that clarify the company's capital trajectory and shareholder impact.